Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Key Takeaways:

• Chris Simon, Haemonetics CEO, will participate in a fireside chat at the Goldman Sachs conference.
• The event is scheduled for Monday, June 9, 2025.
• The announcement was made on May 30, 2025.
• Haemonetics Corporation is listed on the New York Stock Exchange (NYSE: HAE).
• The conference is the 46th Annual Global Healthcare Conference hosted by Goldman Sachs.

Haemonetics CEO to Address Investors at Goldman Sachs Conference

Haemonetics Corporation (NYSE: HAE) announced on May 30, 2025, that its President and CEO, Chris Simon, will participate in a fireside chat with investors at the Goldman Sachs 46th Annual Global Healthcare Conference. The event is set to take place on Monday, June 9, 2025.

Participation in a Major Industry Event

The Goldman Sachs Annual Global Healthcare Conference is in its 46th year, representing a longstanding gathering hosted by Goldman Sachs. Chris Simon’s participation underscores Haemonetics’ engagement with the investor community and the broader healthcare industry.

About Haemonetics Corporation

Based in Boston, Haemonetics Corporation is listed on the New York Stock Exchange under the ticker symbol HAE. The company specializes in providing innovative medical products and solutions.*

Announcement Details

The announcement of Simon’s upcoming appearance was made via a press release on May 30, 2025. The fireside chat format will offer an opportunity for investors to hear directly from the company’s leadership.

Looking Ahead

With the event approaching on June 9, stakeholders and industry observers will be watching for insights from Haemonetics’ top executive. The company’s participation highlights its active role in important industry conversations.

*Note: Since the original content does not provide details about Haemonetics Corporation’s products or solutions, this sentence should be removed to comply with the guideline of not adding new information.

Revised paragraph:

About Haemonetics Corporation

Based in Boston, Haemonetics Corporation is listed on the New York Stock Exchange under the ticker symbol HAE.

Looking Ahead

With the event approaching on June 9, stakeholders and industry observers will be watching for insights from Haemonetics’ top executive. The company’s participation highlights its active role in important industry conversations.